Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminozyme
- Development stage
- Unknown
- Lead developer
- Stadmed
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Aminozyme is a nutritional supplement syrup developed and marketed by Stadmed Private Limited in India. The formulation is a combination of protein hydrolysate (derived from casein), elemental zinc, and a comprehensive B-complex vitamin profile, including thiamine (B1), riboflavin (B2), pyridoxine (B6), niacinamide, and D-panthenol. It is indicated for the improvement of digestion, relief of constipation, and as a general protein and nutrient supplement to address nutritional deficiencies. The product is available as an oral syrup and is typically dispensed via prescription in its primary market.
- Brand names
- Aminozyme
- Other names
- Aminozyme Syrup
Beyond the preview
Go deeper on Aminozyme.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aminozyme.